HillStar Bio Website
3 known investors
Hillstar Bio develops precision immunotherapies for autoimmune diseases, using antibody engineering to selectively deplete pathogenic immune cells while sparing healthy ones. It applies disease-specific genetic markers to identify patient populations most likely to benefit from its targeted treatments.